Evidence map›Paper›PMID 28596237›Full record

ArticleDiabetes2017

The SNARE Protein Syntaxin-1a Plays an Essential Role in Biphasic Exocytosis of the Incretin Hormone Glucagon-Like Peptide 1.

Sarah E Wheeler, Holly M Stacey, Yasaman Nahaei, Stephen J Hale, Alexandre B Hardy, Frank Reimann, Fiona M Gribble, Pierre Larraufie, Herbert Y Gaisano, Patricia L Brubaker

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Enteroendocrine System and Gut Barrier in Metabolic Disorders.International journal of molecular sciences · 2022
    Review
  9. Review
  10. Review
  11. Article
  12. NFAT5 Is Involved in GRP-Enhanced Secretion of GLP-1 by Sodium.International journal of molecular sciences · 2021
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. eLife · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Sarah E WheelerDepartment of Physiology, University of Toronto, Toronto, Ontario, Canada.
Holly M StaceyDepartment of Physiology, University of Toronto, Toronto, Ontario, Canada.
Yasaman NahaeiDepartment of Physiology, University of Toronto, Toronto, Ontario, Canada.
Stephen J HaleDepartment of Physiology, University of Toronto, Toronto, Ontario, Canada.
Alexandre B Hardy3D CFI Centre, University of Toronto, Toronto, Ontario, Canada.
Frank ReimannWellcome Trust-MRC Institute of Metabolic Science, Metabolic Research Laboratories, University of Cambridge, Addenbrooke's Hospital, Cambridge, U.K.
Fiona M GribbleWellcome Trust-MRC Institute of Metabolic Science, Metabolic Research Laboratories, University of Cambridge, Addenbrooke's Hospital, Cambridge, U.K.
Pierre LarraufieWellcome Trust-MRC Institute of Metabolic Science, Metabolic Research Laboratories, University of Cambridge, Addenbrooke's Hospital, Cambridge, U.K.
Herbert Y GaisanoDepartment of Physiology, University of Toronto, Toronto, Ontario, Canada.
Patricia L BrubakerDepartment of Physiology, University of Toronto, Toronto, Ontario, Canada p.brubaker@utoronto.ca.ORCID 0000-0001-7908-788X
University of Toronto · CAWellcome/MRC Institute of Metabolic Science · GB

Funding

Medical Research Council MC_UU_12012/3Medical Research Council MC_UU_12012/5Medical Research Council MRC_MC_UU_12012/3Medical Research Council MRC_MC_UU_12012/5Wellcome TrustWellcome Trust 106262/Z/14/ZWellcome Trust 106263/Z/14/Z
6 · The paper itself

Abstract

Exocytosis of the hormone glucagon-like peptide 1 (GLP-1) by the intestinal L cell is essential for the incretin effect after nutrient ingestion and is critical for the actions of dipeptidyl peptidase 4 inhibitors that enhance GLP-1 levels in patients with type 2 diabetes. Two-photon microscopy revealed that exocytosis of GLP-1 is biphasic, with a first peak at 1-6 min and a second peak at 7-12 min after stimulation with forskolin. Approximately 75% of the exocytotic events were represented by compound granule fusion, and the remainder were accounted for by full fusion of single granules under basal and stimulated conditions. The core SNARE protein syntaxin-1a (syn1a) was expressed by murine ileal L cells. At the single L-cell level, first-phase forskolin-induced exocytosis was reduced to basal (

Indexed as

AnimalsCells, CulturedDiabetes Mellitus, Type 2Enteroendocrine CellsExocytosisFemaleGene Expression RegulationGlucagon-Like Peptide 1GlucoseIleumMaleMiceMice, Inbred C57BLMice, KnockoutObesitySyntaxin 1Glucagon-Like Peptide 1GlucoseSyntaxin 1

Identifiers

PMID28596237
PMCPMC6237272
OpenAlexW2623101650

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.